New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
16:24 EDTSNN, VRX, DDD, SYK, AGN, DSW, TWTROn The Fly: Closing Wrap
Stocks on Wall Street finished lower following a session that began in quiet fashion and remained that way throughout the day. The volume was light, the trading range was tight, and the news flow failed to produce a catalyst that brought buyers into the fray. The S&P 500 touched an all-time high during the session, but was unable to hold onto its narrow gains into the close. Investors will have a busier economic calendar to look forward to tomorrow, which will include the first quarter annualized GDP numbers, weekly jobless claims data, a personal consumption reading, and energy inventory reports. ECONOMIC EVENTS: In the U.S., no major economic data was released. In Europe, a measure of business confidence In the euro area increased to 0.37 in May from 0.28 in April. COMPANY NEWS: Shares of Allergan (AGN) fell $8.90, or 5.39%, to $156.12 after Valeant Pharmaceuticals (VRX) raised the cash portion of its takeover bid by $10 to $58.30, along with 0.83 of a Valeant share and a new contingent value right, or CVR, related to DARPin sales which would provide up to approximately $25.00 per share of additional value. Wells Fargo calculated that, based on Valeant's closing price yesterday, the total new offer for Allergan is around $166 per share, which the firm believes may still be insufficient for Allergan. Following the new bid, which Allergan said it will "carefully review and consider," Valeant shares slid $3.00, or 2.31%, to $126.95. MAJOR MOVERS: Among the notable gainers was Twitter (TWTR), which climbed $3.26, or 10.69%, to $33.77 after Japanese bank Nomura upgraded the stock to Buy from Neutral in a note to investors. Also higher was Stryker (SYK), which rose $2.28, or 2.84%, to $82.64 after Financial Times reported this morning that the company was preparing a takeover bid for its U.K-based rival Smith & Nephew (SNN) and Stryker's CEO reportedly confirmed in an interview that the company was in the early stages of evaluating a potential acquisition of its peer. However, Stryker, at the urging of a British regulator, said it does not intend to make an offer for Smith & Nephew at this time, but reserved the right to make a future bid. Smith & Nephew shares trading in New York advanced $2.71, or 3.37% to $83.05. Among the noteworthy losers was shoe retailer DSW (DSW), which fell $8.90, or 27.37%, to $23.62 and was downgraded at Sterne Agee and Citigroup after its quarter report and yearly profit outlook disappointed. Also lower was 3D Systems (DDD), which slipped $6.20, or 10.95%, to $50.44 after announcing a secondary offering of about 6 million shares. INDEXES: The Dow fell 42.32, or 0.25%, to 16,633.18, the Nasdaq dropped 11.99, or 0.28%, to 4,225.08, and the S&P 500 declined 2.13, or 0.11%, to 1,909.78.
News For AGN;VRX;TWTR;SYK;SNN;DSW;DDD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 20, 2015
07:19 EDTTWTRTwitter remains under-owned into Q1 results, says Deutsche Bank
Deutsche Bank says that while the set-up for shares of Twitter into the Q1 earnings report isn't as favorable as last quarter, the stock remains under-owned relative to most large cap Internet stocks. Deutsche notes its channel checks on Twitter have been "solid" all quarter around improving monetization trends. The firm sees "plenty" more upside for shares of Twitter and keeps a Buy rating on the name with a $65 price target.
April 17, 2015
16:11 EDTTWTROptions Update; April 17, 2015
Subscribe for More Information
11:48 EDTDSWDSW management to meet with William Blair
Subscribe for More Information
10:17 EDTTWTRStocks with call strike movement; PBR TWTR
Subscribe for More Information
09:34 EDTTWTRTwitter Q1 U.S. ad spending to moderate, says OTR Global
Subscribe for More Information
08:34 EDTTWTRTwitter May volatility elevated into Q1 and outlook
Subscribe for More Information
April 16, 2015
16:02 EDTTWTROptions Update; April 16, 2015
Subscribe for More Information
09:23 EDTDSWDSW comp momentum likely to drive Q1 upside, says Cleveland Research
Cleveland Research said strong comp momentum indicates potential margin upside to Q1 and 1 H. The firm said continued outperformance and favorable industry trends increases its confidence in potential upside and raised estimates above consensus.
April 15, 2015
16:01 EDTTWTROptions Update; April 15, 2015
iPath S&P 500 VIX Short-Term Futures down 49c to 21.90. Option volume leaders: AAPL NFLX C PBR KMI RIG MCP TWTR GILD BAC according to Track Data.
13:35 EDTTWTRTwitter introduces new twitter.com on desktop to U.S
Subscribe for More Information
09:35 EDTTWTRActive equity options trading on open
Subscribe for More Information
08:02 EDTTWTRTwitter Periscope may be next big thing in social media, says Baird
Subscribe for More Information
April 14, 2015
19:05 EDTTWTRTwitter to launch redesigned homepage in coming days, Slate says
Subscribe for More Information
16:00 EDTTWTROptions Update; April 14, 2015
Subscribe for More Information
14:48 EDTSYKZimmer, Stryker have mixed read through from J&J results, says Wells Fargo
Subscribe for More Information
06:30 EDTTWTRTwitter threatens Periscope users who illegally streamed 'GoT,' Mashable says
Subscribe for More Information
April 13, 2015
16:01 EDTTWTROptions Update; April 13, 2015
Subscribe for More Information
12:05 EDTTWTRStocks with call strike movement; TWTR FXI
Twitter (TWTR) September 60 call option implied volatility increased 2% to 43, Twitter iShares Trust FTSE/Xinhua China 25 Fund (FXI) July 57 call option implied volatility decreased 11% to 33 according to IVolatility.
10:15 EDTSYKHigh option volume stocks
Subscribe for More Information
06:00 EDTDDDStocks with implied volatility above IV index mean; DDD HOT
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use